Andlauer Healthcare Group Inc. (TSX: AND)

Andlauer Healthcare Group Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	66.14	76.28	89.95	37.71	29.77
Depreciation & Amortization	68.15	64.45	42.72	28.02	25.71
Share-Based Compensation	0.93	1.3	1.86	3.04	1.39
Other Operating Activities	-30.8	-4.9	-50.44	-17.77	4.13
Operating Cash Flow	104.42	137.13	84.09	51	61
Operating Cash Flow Growth	-23.85%	63.07%	64.87%	-16.39%	16.55%
Capital Expenditures	-25.59	-27.96	-9.67	-5.44	-6.17
Acquisitions	1.74	-19.32	-173.97	-14.93	0
Change in Investments	-	-	-15.3	-	-
Other Investing Activities	-	1.72	15.55	0	-
Investing Cash Flow	-23.85	-45.56	-183.38	-20.37	-6.17
Dividends Paid	-14.2	-10.88	-7.85	-7.93	-112.02
Common Stock Issued	0	-0.06	93.77	0	172.5
Share Repurchases	-18.84	0	0	0	50
Other Financing Activities	-90.82	-40.64	7.98	-11.27	-100.27
Financing Cash Flow	-86.18	-51.59	93.89	-19.2	-89.78
Net Cash Flow	-6.12	40.87	-5.16	11.44	-34.95
Free Cash Flow	78.83	109.17	74.42	45.56	54.84
Free Cash Flow Growth	-27.79%	46.69%	63.34%	-16.91%	10.22%
Free Cash Flow Margin	12.17%	16.84%	16.91%	14.50%	18.91%
Free Cash Flow Per Share	1.85	2.56	1.86	1.18	1.45

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.